Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients diagnosed with mCRC who have been previously treated with, or are not considered candidates for, other locally approved standard treatment(s) and for whom the decision has been made per investigator's routine treatment practice to prescribe regorafenib.
Patients enrolled in NIS CORRELATE in Austria
Signed patient informed consent for local OS
You may not be if
Subjects unwilling to complete all questionnaires involved in the local OS
Subjects unwilling to wear the pedometer
Clareo Health | Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer
